News Focus
News Focus
icon url

bhp1rtp

01/30/15 3:49 PM

#21998 RE: leifsmith #21995

Yes I agree with your statement

"However, since the therapeutic effect to be measured is reduction of inflammation, and not the consequence of inflammation in any specific disease, it seems that more trials, targeting specific diseases, will be required before a product can be marketed.

The length of such trials, in many cases, might be short."